$BTCS
BTCS Inc. Stock $btcs

$btcs Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000149315223040107 Filed on November 09, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$326.1K	$316.2K	$344.2K
YoY Change	20.39%	-8.12%	6.44%
Cost Of Revenue	$81.05K	$83.10K	$82.20K
YoY Change	-27.94%	1.09%	14.66%
Gross Profit	$245.1K	$233.1K	$262.0K
YoY Change	54.7%	-11.01%	4.09%
Gross Profit Margin	75.15%	73.72%	76.12%
Selling, General & Admin	$1.033M	$285.4K	$441.7K
YoY Change	13.91%	-35.39%	-91.23%
% of Gross Profit	421.46%	122.41%	168.6%
Research & Development	$156.2K	$148.5K	$126.9K
YoY Change	-4.25%	17.08%	-53.69%
% of Gross Profit	63.75%	63.71%	48.42%
Depreciation & Amortization	$5.030K	$0.00	$1.130K
YoY Change	326.27%	-100.0%	707.14%
% of Gross Profit	2.05%	0.0%	0.43%
Operating Expenses	$1.189M	$1.158M	$1.363M
YoY Change	11.14%	-15.06%	-74.33%
Operating Profit	-$944.1K	-$925.1K	-$1.101M
YoY Change	3.57%	-16.02%	-78.23%
Interest Expense	-$1.410M	$60.00K	$91.38K
YoY Change	-373.43%	-34.34%	-93.59%
% of Operating Profit
Other Income/Expense, Net	$11.99M	$285.0K	$71.25K
YoY Change		300.0%	-95.0%
Pretax Income	$10.89M	-$640.0K	-$1.030M
YoY Change	-879.53%	-37.88%	-73.19%
Income Tax
% Of Pretax Income
Net Earnings	$10.89M	-$640.1K	-$1.030M
YoY Change	-879.53%	-37.87%	-73.19%
Net Earnings / Revenue	3339.35%	-202.4%	-299.32%
Basic Earnings Per Share		-$0.04	-$0.08
Diluted Earnings Per Share	$0.75	-$0.04	-$79.54K
COMMON SHARES
Basic Shares Outstanding	14.37M shares	14.33M shares	12.97M shares
Diluted Shares Outstanding		14.32M shares	12.95M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.458M	$850.0K	$2.889M
YoY Change	-35.09%	-70.58%	-24.35%
Cash & Equivalents	$1.458M	$753.2K	$2.900M
Short-Term Investments		$100.0K
Other Short-Term Assets	$25.29M	$8.050M	$2.830M
YoY Change	1196.06%	184.43%	499.13%
Inventory
Prepaid Expenses	$62.46K	$107.4K	$207.1K
Receivables
Other Receivables
Total Short-Term Assets	$27.04M	$8.904M	$5.719M
YoY Change	544.06%	55.68%	33.27%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.49K	$12.00K	$12.33K
YoY Change	-5.94%	-2.67%	184.76%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$100.0K
YoY Change
Other Assets	$0.00	$0.00	$5.600M
YoY Change	-100.0%	-100.0%	-36.64%
Total Long-Term Assets	$110.5K	$12.00K	$5.612M
YoY Change	-98.07%	-99.79%	-36.53%
TOTAL ASSETS
Total Short-Term Assets	$27.04M	$8.904M	$5.719M
Total Long-Term Assets	$110.5K	$12.00K	$5.612M
Total Assets	$27.15M	$8.916M	$11.33M
YoY Change	173.72%	-21.32%	-13.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$55.06K	$90.00K	$100.9K
YoY Change	-28.24%	-10.78%	-1.22%
Accrued Expenses	$767.2K	$413.8K	$317.2K
YoY Change	105.86%	30.45%	21046.87%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$980.9K	$485.1K	$1.030M
YoY Change	67.27%	-52.89%	-77.89%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$980.9K	$485.1K	$1.030M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$980.9K	$490.0K	$1.030M
YoY Change	67.27%	-52.41%	-77.89%
SHAREHOLDERS EQUITY
Retained Earnings	-$138.7M	-$154.6M	-$150.1M
YoY Change	-8.45%	2.98%
Common Stock	$15.32K	$14.37K	$160.4M
YoY Change	-99.99%	-99.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$26.17M	$8.431M	$10.30M
YoY Change
Total Liabilities & Shareholders Equity	$27.15M	$8.916M	$11.33M
YoY Change	173.72%	-21.32%	-13.72%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	$10.89M	-$640.1K	-$1.030M
YoY Change	-879.53%	-37.87%	-73.19%
Depreciation, Depletion And Amortization	$5.030K	$0.00	$1.130K
YoY Change	326.27%	-100.0%	707.14%
Cash From Operating Activities	-$872.3K	-$640.0K	-$780.6K
YoY Change	34.75%	-18.01%	27.26%
INVESTING ACTIVITIES
Capital Expenditures	-$240.00	$10.00K	-$135.1K
YoY Change	-100.13%	-107.4%	-86.08%
Acquisitions
YoY Change
Other Investing Activities	-$4.240K	$280.0K	$122.6K
YoY Change	-108.02%	128.44%
Cash From Investing Activities	-$4.000K	$270.0K	-$12.56K
YoY Change	-96.83%	-2249.68%	-98.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.578M	180.0K	490.7K
YoY Change	4957.02%	-63.32%	-172.9%
NET CHANGE
Cash From Operating Activities	-872.3K	-640.0K	-780.6K
Cash From Investing Activities	-4.000K	270.0K	-12.56K
Cash From Financing Activities	1.578M	180.0K	490.7K
Net Change In Cash	701.5K	-190.0K	-302.4K
YoY Change	-194.52%	-37.18%	-86.6%
FREE CASH FLOW
Cash From Operating Activities	-$872.3K	-$640.0K	-$780.6K
Capital Expenditures	-$240.00	$10.00K	-$135.1K
Free Cash Flow	-$872.0K	-$650.0K	-$645.4K
YoY Change	5.53%	0.71%	-280.76%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001436229
CY2022Q4	BTCS	Stable Coins StableCoins		usd
CY2023Q3	BTCS	Staked Digital Assets Currencies Non Current StakedDigitalAssetsCurrenciesNonCurrent		usd
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q3	BTCS	Distributions To Warrant Holders DistributionsToWarrantHolders		usd
	BTCS	Distributions To Warrant Holders DistributionsToWarrantHolders		usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther		usd
	BTCS	Blockchain Network Fees BlockchainNetworkFees		usd
	BTCS	Sale Of Nonproductive Crypto Assets SaleOfNonproductiveCryptoAssets		usd
	BTCS	Increase Decrease In Stable Coins IncreaseDecreaseInStableCoins		usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
CY2023Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	12001	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	5719776	usd
CY2023Q3	us-gaap	Assets Assets	8915653	usd
CY2022Q4	us-gaap	Assets Assets	9917575	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40792
	dei	Entity Registrant Name EntityRegistrantName	BTCS Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-1096644
	dei	Entity Address Address Line1 EntityAddressAddressLine1	9466 Georgia Avenue #124
	dei	Entity Address City Or Town EntityAddressCityOrTown	Silver Spring
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20910
	dei	City Area Code CityAreaCode	(202)
	dei	Local Phone Number LocalPhoneNumber	430-6576
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001
	dei	Trading Symbol TradingSymbol	BTCS
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	14373186	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	753233	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2146783	usd
CY2023Q3	BTCS	Stable Coins StableCoins	29794	usd
CY2023Q3	BTCS	Crypto Assets Currencies CryptoAssetsCurrencies	101387	usd
CY2022Q4	BTCS	Crypto Assets Currencies CryptoAssetsCurrencies	982	usd
CY2023Q3	BTCS	Staked Crypto Assets Currencies StakedCryptoAssetsCurrencies	7811809	usd
CY2022Q4	BTCS	Staked Crypto Assets Currencies StakedCryptoAssetsCurrencies	1826307	usd
CY2023Q3	us-gaap	Investments And Cash InvestmentsAndCash	100000	usd
CY2022Q4	us-gaap	Investments And Cash InvestmentsAndCash	100000	usd
CY2023Q3	us-gaap	Investments Investments	100000	usd
CY2022Q4	us-gaap	Investments Investments	100000	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	107429	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	123727	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	8903652	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	4197799	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12001	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11152	usd
CY2022Q4	BTCS	Staked Digital Assets Currencies Non Current StakedDigitalAssetsCurrenciesNonCurrent	5708624	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	92659	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	76727	usd
CY2023Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	321144	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	295935	usd
CY2023Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	71250	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	213750	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	485053	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	586412	usd
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	97500000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	97500000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14373186	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14373186	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13107149	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13107149	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	14374	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	13108	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	160410794	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	160800263	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-154554101	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-151482208	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	8430600	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	9331163	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8915653	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9917575	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	316242	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	344196	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1013503	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1421560	usd
CY2023Q3	us-gaap	Revenues Revenues	316242	usd
CY2022Q3	us-gaap	Revenues Revenues	344196	usd
	us-gaap	Revenues Revenues	1013503	usd
	us-gaap	Revenues Revenues	1421560	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	83100	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	82203	usd
	us-gaap	Cost Of Revenue CostOfRevenue	278726	usd
	us-gaap	Cost Of Revenue CostOfRevenue	313972	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	233142	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	261993	usd
	us-gaap	Gross Profit GrossProfit	734777	usd
	us-gaap	Gross Profit GrossProfit	1107588	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	283239	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	432956	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1510637	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1595296	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	148525	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	126857	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	531053	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	448579	usd
CY2023Q3	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	409960	usd
CY2022Q3	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	669792	usd
	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	1450546	usd
	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	2731713	usd
CY2023Q3	us-gaap	Marketing Expense MarketingExpense	2155	usd
CY2022Q3	us-gaap	Marketing Expense MarketingExpense	8765	usd
	us-gaap	Marketing Expense MarketingExpense	11121	usd
	us-gaap	Marketing Expense MarketingExpense	74249	usd
CY2023Q3	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	372441	usd
CY2022Q3	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	145247	usd
	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	1251950	usd
	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	12347472	usd
CY2023Q3	BTCS	Realized Gains On Crypto Asset Currency Transactions RealizedGainsOnCryptoAssetCurrencyTransactions	58107	usd
CY2022Q3	BTCS	Realized Gains On Crypto Asset Currency Transactions RealizedGainsOnCryptoAssetCurrencyTransactions	20126	usd
	BTCS	Realized Gains On Crypto Asset Currency Transactions RealizedGainsOnCryptoAssetCurrencyTransactions	806137	usd
	BTCS	Realized Gains On Crypto Asset Currency Transactions RealizedGainsOnCryptoAssetCurrencyTransactions	489682	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	1158213	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	1363491	usd
	us-gaap	Operating Expenses OperatingExpenses	3949170	usd
	us-gaap	Operating Expenses OperatingExpenses	16707627	usd
CY2023Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-285000	usd
CY2022Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-71250	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-142500	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1140000	usd
	BTCS	Distributions To Warrant Holders DistributionsToWarrantHolders	35625	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	285000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	71250	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	142500	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1104375	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-640071	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1030248	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3071893	usd
	us-gaap	Net Income Loss NetIncomeLoss	-14495664	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.15
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.15
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14317750	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14317750	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12952645	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12952645	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13957097	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13957097	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12616805	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12616805	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	9331163	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1113818	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	1057512	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3071893	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	8430600	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	12103443	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	11095132	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	2233608	usd
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-634557	usd
	us-gaap	Net Income Loss NetIncomeLoss	-14495664	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	10301962	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	8615295	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	187317	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	268059	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-640071	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	8430600	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	10390713	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	10390713	usd
CY2022Q3	BTCS	Issuance Of Common Stock Net Of Offering Cost Atthemarket Offering IssuanceOfCommonStockNetOfOfferingCostAtthemarketOffering	490692	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	450805	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1030248	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	10301962	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	10301962	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3071893	usd
	us-gaap	Net Income Loss NetIncomeLoss	-14495664	usd
	us-gaap	Depreciation Depreciation	3521	usd
	us-gaap	Depreciation Depreciation	2862	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1057512	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2233608	usd
	BTCS	Validator Revenue ValidatorRevenue	1013503	usd
	BTCS	Validator Revenue ValidatorRevenue	1421560	usd
	BTCS	Blockchain Network Fees BlockchainNetworkFees	1321	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-142500	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1140000	usd
	BTCS	Sale Of Nonproductive Crypto Assets SaleOfNonproductiveCryptoAssets	2547322	usd
	BTCS	Realized Gain On Crypto Assets Transactions RealizedGainOnCryptoAssetsTransactions	806137	usd
	BTCS	Realized Gain On Crypto Assets Transactions RealizedGainOnCryptoAssetsTransactions	489682	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	35000	shares
	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	1251950	usd
	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	12347472	usd
	BTCS	Increase Decrease In Stable Coins IncreaseDecreaseInStableCoins	-29794	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-16298	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-117473	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	15932	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-37842	usd
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	25209	usd
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	205237	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2693405	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-129453	usd
	BTCS	Purchase Of Productive Crypto Assets Currencies For Validating PurchaseOfProductiveCryptoAssetsCurrenciesForValidating	1804482	usd
	BTCS	Purchase Of Productive Crypto Assets Currencies For Validating PurchaseOfProductiveCryptoAssetsCurrenciesForValidating	9274055	usd
	BTCS	Sale Of Productive Crypto Assets Currencies SaleOfProductiveCryptoAssetsCurrencies	1994890	usd
	BTCS	Sale Of Productive Crypto Assets Currencies SaleOfProductiveCryptoAssetsCurrencies	432716	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5276	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5408	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	905	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	186037	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8846747	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	630801	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1113818	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	11095132	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1113818	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10464331	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1393550	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1488131	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2146783	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1400867	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	753233	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2888998	usd
	BTCS	Series V Preferred Stock Distribution SeriesVPreferredStockDistribution	2559533	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	490000	usd
	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	12347000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	806000	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zEOWsrTjTnd2" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_zTaogXHJwvje">Reclassifications</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior period amounts have been reclassified in order to conform with the current period presentation. These reclassifications have no impact on the Company’s previously reported net income (loss).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3	us-gaap	Cash Cash	753000	usd
CY2022Q4	us-gaap	Cash Cash	2147000	usd
CY2023Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	102000	usd
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	1682000	usd
	us-gaap	Impairment Losses Related To Real Estate Partnerships ImpairmentLossesRelatedToRealEstatePartnerships	1252000	usd
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.02
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84B_eus-gaap--UseOfEstimates_z9MBIVzRnqxi" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_ziyUGBdyaOUf">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared in conformity with U.S. GAAP. This requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the period. The Company’s significant estimates and assumptions include the recoverability and useful lives of indefinite life intangible assets, stock-based compensation, and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates, including the carrying amount of the indefinite life intangible assets, could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates and assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Income Tax Examination Likelihood Of Unfavorable Settlement IncomeTaxExaminationLikelihoodOfUnfavorableSettlement	Tax positions are recognized only when it is more likely than not (i.e., likelihood of greater than 50%), based on technical merits, that the position would be sustained upon examination by taxing authorities. Tax positions that meet the more likely than not threshold are measured using a probability-weighted approach as the largest amount of tax benefit that is greater than 50% likely of being realized upon settlement.
	us-gaap	Preferred Stock Conversion Basis PreferredStockConversionBasis	The Series V: (i) is non-convertible, (ii) has a 20% liquidation preference over the shares of common stock, (iii) is non-voting and (iv) has certain rights to dividends and distributions (at the discretion of the Board).
	us-gaap	Payments Of Dividends PaymentsOfDividends	0	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	635000	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	11000	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	74000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3493899	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3843187	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3493899	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3843187	shares
CY2023Q3	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	100000	usd
CY2023Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	71250	usd
CY2022Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	100000	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	213750	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	97500000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	975000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	975000000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1150000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.15
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y3M18D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	35000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.81
	BTCS	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Grants In Period SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGrantsInPeriod	P4Y10M24D
	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	95000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue	11100
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1150000	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.14
	BTCS	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm	P2Y6M
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1135000	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	2.16
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P2Y6M
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	1521296	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.9730	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.0372	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0410	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0132	pure
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1590552	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	3.34
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	50000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.63
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	9153	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	4.37
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1631399	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	3.25
	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	1	pure
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	252095	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	481284	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	767315	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2377199	usd
CY2023Q3	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	321144	usd
CY2022Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	295935	usd
CY2023Q3	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	92659	usd
CY2022Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	76727	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	413803	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	372662	usd
CY2023Q3	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	321000	usd
CY2022Q4	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	284000	usd
	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	45000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-154554000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3072000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2693000	usd

Files In Submission

Name	View Source	Status
btcs-20230930_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
0001493152-23-040107-index-headers.html	Edgar Link	pending
0001493152-23-040107-index.html	Edgar Link	pending
0001493152-23-040107.txt	Edgar Link	pending
0001493152-23-040107-xbrl.zip	Edgar Link	pending
btcs-20230930.xsd	Edgar Link	pending
btcs-20230930_cal.xml	Edgar Link	unprocessable
btcs-20230930_def.xml	Edgar Link	unprocessable
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
btcs-20230930_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BTCS
BTCS Inc. Stock $btcs

2023 Q4 Form 10-Q Financial Statement

#000149315223040107 Filed on November 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BTCS BTCS Inc. Stock $btcs

2023 Q4 Form 10-Q Financial Statement

#000149315223040107 Filed on November 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BTCS
BTCS Inc. Stock $btcs